Tacrolimus as second-line therapy in acute severe autoimmune hepatitis
Sign Up to like & getrecommendations! Published in 2020 at "Scandinavian Journal of Gastroenterology"
DOI: 10.1080/00365521.2020.1867890
Abstract: Autoimmune hepatitis (AIH) may present with features of acute liver failure (severe jaundice, coagulopathy and encephalopathy) which is called as acute severe AIH (ASAIH). Diagnosis and management of this group of patients is very difficult… read more here.
Keywords: autoimmune hepatitis; acute severe; gastroenterology; therapy ... See more keywords
Identification of circulating microRNAs as potential biomarkers for hepatic necroinflammation in patients with autoimmune hepatitis
Sign Up to like & getrecommendations! Published in 2022 at "BMJ Open Gastroenterology"
DOI: 10.1136/bmjgast-2022-000879
Abstract: Objective MicroRNAs (miRNAs) are implicated in the pathogenesis of autoimmune diseases and could be biomarkers of disease activity. This study aimed to identify highly expressed circulating miRNAs in patients with autoimmune hepatitis (AIH) and to… read more here.
Keywords: autoimmune hepatitis; patients autoimmune; identification circulating; patients aih ... See more keywords
Clinical characteristics and outcomes of COVID-19 in patients with autoimmune hepatitis: A population-based matched cohort study
Sign Up to like & getrecommendations! Published in 2023 at "World Journal of Hepatology"
DOI: 10.4254/wjh.v15.i1.68
Abstract: BACKGROUND Patients with autoimmune hepatitis (AIH) require life-long immunosuppressive agents that may increase the risk of poor coronavirus disease 2019 (COVID-19) outcomes. There is a paucity of large data at the population level to assess… read more here.
Keywords: matched cohort; disease; risk; cohort ... See more keywords